Fractional Chief Revenue Officer for Biotech: Commercial Leadership Through Launch

A chief revenue officer (CRO) is the executive responsible for how a company earns revenue. That commonly spans sales, marketing, pricing and access strategy, customer success, and the way those functions work together. A fractional chief revenue officer provides this kind of leadership on a part-time, interim, or project basis rather than as a full-time employee.

In biotech, the role has a particular flavor. Many companies spend years focused on science, development, and regulatory milestones, and may have little or no in-house commercial leadership when a product launch comes into view. A biotech-focused CRO is someone who may bring commercial thinking into that picture early: who the customers are, how they make decisions, and what a launch might require.

A note on terms: in this page, CRO means chief revenue officer. It is not the same as a clinical research organization, the outsourced partner that supports clinical trials. The two roles are unrelated, and Fierce CRO keeps those topics separate.

Traditionally, biotech companies have approached commercialization in several ways. Some hire a full-time chief commercial officer or head of sales and marketing, often as a late-stage program moves closer to approval. Others lean on founders, the chief executive, or business development leaders to cover commercial questions alongside their existing duties.

Other companies work with outside consultants, agencies, or contract commercial organizations for specific needs such as market research, launch planning, or field sales support. Some partner with or license to a larger company that already has commercial infrastructure. Each path involves different tradeoffs in cost, control, speed, and the amount of internal capability built.

None of these approaches is inherently right or wrong. The best fit often depends on the company's stage, funding, product type, team, and long-term goals. A fractional model is simply one more option, sitting between doing it all internally and handing it all to outside partners.

The right fractional CRO may help a biotech team think through commercial strategy before and during a launch. That could include clarifying the target customers, shaping how the commercial function might be organized, sequencing hires, and aligning leadership around what needs to happen as the company moves toward market. Because the engagement is part-time or time-bound, it may offer senior perspective without a full-time executive commitment.

A first conversation is generally an exploration. Expect to talk about where your product and company stand, what commercial capability already exists, and what you hope outside leadership would accomplish. Good questions to ask a prospective CRO include: What experience do you have with companies at my stage and in my product category? How do you typically structure an engagement, and what would your time commitment look like? How would you work with my existing team, board, and other partners? How do you handle handoff if I later hire a full-time commercial leader?

It also helps to ask how the CRO describes their own background and to verify it yourself, since listed CROs are independent and the directory does not vouch for individual experience or qualifications. No CRO can promise a match, a hire, or a business outcome. Before signing anything, confirm engagement terms, including any retainer, placement fee, or confidentiality provisions, with your own legal counsel.